Yahoo
Tel Aviv - Delayed Quote ILA

BrainsWay Ltd. (BWAY.TA)

3,733.00 +77.00 (+2.11%)
At close: October 30 at 1:44:52 PM GMT+2
Chart Range Bar
Loading chart for BWAY.TA
  • Previous Close 3,656.00
  • Open 3,656.00
  • Bid --
  • Ask 3,733.00 x --
  • Day's Range 3,656.00 - 3,784.00
  • 52 Week Range 2,391.00 - 5,165.00
  • Volume 45,080
  • Avg. Volume 80,199
  • Market Cap (intraday) 1.503B
  • Beta (5Y Monthly) 0.10
  • PE Ratio (TTM) 51.14
  • EPS (TTM) 0.73
  • Earnings Date Nov 10, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

www.brainsway.com

129

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is TA-125 (^TA125.TA) .

YTD Return

BWAY.TA
19.46%
TA-125 (^TA125.TA)
7.70%

1-Year Return

BWAY.TA
33.66%
TA-125 (^TA125.TA)
17.90%

3-Year Return

BWAY.TA
470.36%
TA-125 (^TA125.TA)
137.56%

5-Year Return

BWAY.TA
0.00%
TA-125 (^TA125.TA)
0.00%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 17.11M
Earnings 2.71M
Profit Margin 15.84%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
5M
10M
15M
12.0%
14.0%
16.0%
18.0%
20.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.56%

  • Return on Assets (ttm)

    4.05%

  • Return on Equity (ttm)

    12.82%

  • Revenue (ttm)

    60.7M

  • Net Income Avi to Common (ttm)

    9.44M

  • Diluted EPS (ttm)

    0.73

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    62.11M

  • Total Debt/Equity (mrq)

    9.01%

  • Levered Free Cash Flow (ttm)

    -6.16M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: